María Páez de la Cadena Tortosa-rekin lankidetzan egindako argitalpenak (27)

2022

  1. Evaluation of Blood Soluble CD26 as a Complementary Biomarker for Colorectal Cancer Screening Programs

    Cancers, Vol. 14, Núm. 19

2021

  1. The mechanism of sitagliptin inhibition of colorectal cancer cell lines' metastatic functionalities

    IUBMB Life, Vol. 73, Núm. 5, pp. 761-773

2020

  1. CD26-Related Serum Biomarkers: SCD26 Protein, DPP4 Activity, and Anti-CD26 Isotype Levels in a Colorectal Cancer-Screening Context

    Disease Markers, Vol. 2020

  2. Validation of Calprotectin As a Novel Biomarker For The Diagnosis of Pleural Effusion: a Multicentre Trial

    Scientific Reports, Vol. 10, Núm. 1

  3. Value of serum NEUROG1 methylation for the detection of advanced adenomas and colorectal cancer

    Diagnostics, Vol. 10, Núm. 7

2019

  1. Surface expression marker profile in colon cancer cell lines and sphere-derived cells suggests complexity in CD26+ cancer stem cells subsets

    Biology Open, Vol. 8, Núm. 7

2018

  1. A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples

    Clinical Epigenetics, Vol. 10, Núm. 1

2017

  1. A simple electroelution method for rapid protein purification: Isolation and antibody production of alpha toxin from Clostridium septicum

    PeerJ, Vol. 2017, Núm. 6

  2. Evaluation of an automated commercial ELISA method for calprotectin determination in pleural fluid

    Clinical Chemistry and Laboratory Medicine

  3. Highly sensitive marker panel for guidance in lung cancer rapid diagnostic units

    Scientific Reports, Vol. 7

  4. Relevance of matrix metalloproteases in non-small cell lung cancer diagnosis

    BMC Cancer, Vol. 17, Núm. 1

2016

  1. Evaluation of serum nucleoside diphosphate kinase A for the detection of colorectal cancer

    Scientific Reports, Vol. 6

2015

  1. Serum calprotectin, CD26 and EGF to establish a panel for the diagnosis of lung cancer

    PLoS ONE, Vol. 10, Núm. 5

  2. Serum dipeptidyl peptidase IV activity and sCD26 concentration in patients with choroidal nevus or uveal melanoma

    Clinica Chimica Acta

  3. Serum sCD26 for colorectal cancer screening in family-risk individuals: Comparison with faecal immunochemical test

    British Journal of Cancer, Vol. 112, Núm. 2, pp. 375-381

2014

  1. Postoperative serum levels of sCD26 for surveillance in colorectal cancer patients

    PLoS ONE, Vol. 9, Núm. 9

2013

  1. Decreased expression of alpha-L-fucosidase gene FUCA1 in human colorectal tumors

    International Journal of Molecular Sciences, Vol. 14, Núm. 8, pp. 16986-16998

  2. Levels of PEDF in pleural effusions from lung adenocarcinoma and benign disease patients

    Disease Markers, Vol. 34, Núm. 6, pp. 425-430

  3. Posibles nuevos marcadores para diagnóstico clínico contra el cáncer: los exosomas

    Investigación: cultura, ciencia y tecnología, Núm. 10, pp. 7-13

  4. Preoperative serum CA 72.4 as prognostic factor of recurrence and death, especially at TNM stage II, for colorectal cancer

    BMC Cancer, Vol. 13